Leadership Team

ELS is made up of pharmacologists, MDs, biologists, mathematicians, and veterans of the business world who are motivated by the opportunity to improve medical outcomes and patient safety.

Sundar Srinivasan, CEO

Sundar Srinivasan founded Emerald Lake Safety after a wide-ranging career in investments and business. He was formerly a Portfolio Manager at Elliott Management, a $35bn+ global investment fund where he worked extensively in both private equity and public securities. Mr. Srinivasan has chaired or served on numerous public and private company boards, including Blue Knight Energy Partners, Dice, Answer Financial, James River and URL Pharma. Prior to Elliott, Mr. Srinivasan was a Vice President in the Investment Banking Group at Morgan Stanley and a Management Consultant at Oliver Wyman.

 

Brendan Magrab, Commercial and IP

Brendan Magrab is the former CEO, COO, and CLO of URL Pharma, a private specialty pharma company acquired by Takeda for over $1bn. Prior to his 25+ year tenure in the pharmaceutical industry, Mr. Magrab worked in private practice, clerked on the Federal Circuit Court of Appeals in Washington DC, and served as a US patent examiner.

 

Eric Stein, Business Development

Eric Stein has an extensive business and investment background as a former Partner and Managing Director of FSI Group, a multi-billion dollar investment manager. Recently, Mr. Stein served in multiple government roles, including Special Advisor to the Secretary for Foreign Assistance and Budget Planning at the State Department and Assistant to the Secretary for Finance and Budget at the U.S. Treasury Department. Mr. Stein began his career as an analyst at Morgan Stanley.

 

Christina Chow, PhD, Research

Christina Chow has spent her entire career in pharmacology research. At ELS, Dr. Chow leads collaborations with external scholars and researchers on clinical studies and scientific analyses. Before joining the ELS team, Dr. Chow was a Postdoctoral Researcher at the Robert H. Lurie Comprehensive Cancer Center at Northwestern University and a former Visiting Research Specialist at the Research Center for Advanced Science and Technology at The University of Tokyo. Dr. Chow received her PhD in Pharmacology at the University of Illinois at Chicago.